Back to search results

Observational Study of Pancreatic Cysts

This observational study aims to better understand pancreatic cysts, which are often found incidentally during imaging tests. Researchers want to learn how these cysts change over time and develop better ways to tell if a cyst is harmless or has the potential to become cancerous. They will do this by looking at your medical records, including clinical information, imaging results, and biomarker (biological markers) characteristics. The goal is to improve how doctors diagnose and manage pancreatic cysts, potentially reducing unnecessary procedures for benign (non-cancerous) cysts and ensuring appropriate follow-up for those that might be more serious. You may be eligible to participate if you are an adult aged 18 or older and have been referred for a pancreatic cyst assessment. The study plans to enroll 5000 participants, but its current status is unclear.

Study design
This is an observational study, meaning researchers will collect information about your pancreatic cysts over time. It aims to enroll 5000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will assess the clinical utility of Compcyst in pancreatic cysts as assessed by patient chart review, measured at 15 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04473794

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Recruiting
Not specifiedAges 18+Observational
Johns Hopkins University
~5,000 participants
Updated 2026-03-02 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinical utility of Compcyst in pancreatic cysts as assessed by patient chart review
Measured over 15 years

Conditions

Pancreatic Neoplasms
Pancreas Cancer

Explore related trials

Malignant Pancreatic NeoplasmPancreatic Neoplasm

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Elham Afghani, MD MPH · PRINCIPAL_INVESTIGATOR · Johns Hopkins University

Who to contact

Elham Afghani, MD MPH
[email protected]
410-614-6708
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adult patients age 18 years and older
Referred for assessment of a pancreatic cyst.

Exclusion

Medically ill patients with American Society of Anesthesiologists class 4 or greater.
Inability to provide informed consent.
Pregnancy or lactation.

What this trial measures

  • Clinical utility of Compcyst in pancreatic cysts as assessed by patient chart review15 years

    Compcyst is part of the new standard of care diagnosis of precancerous and benign cystic lesions. Patient charts will be reviewed for clinical, radiological, surgical and pathologic information (all combined into a composite) that will be used to determine if Compcyst as part of the new standard of care is better than the diagnostic measure in the old standard of care in detecting precancerous and benign cystic lesions. Patient records over a 15-year period will be reviewed.